Recent content from Joe Carlson
Its largest division has already taken a hit, and the complexity of a merger hasn't started yet.
Just days before trial, medical device maker Boston Scientific Corp. has agreed to pay the Internal Revenue Service $275 million plus interest to settle more…
Regulators want a closer look, but the two expect it finalized by year's end.
Move comes as Mazor Robotics is set to announce a new guidance system.
Franken had asked it questions about late Medtronic report.
It will pay $600,000 for allegedly missing deadlines to report price information.
The company faces more than 36,000 product liability cases related to the devices.
A judge sided with the company in a yearslong dispute with the IRS.
Lewis Pell's proxy challenge prevailed and now shareholders wonder about the next chapter.
The company said a trial with a new insulin pump showed progress in controlling glucose levels.
Senators press Justice Dept. on its prosecution of Vascular Solutions.
Deal for Mpls. firm comes as hospitals look for lower-priced joint-replacement options.
A proxy fight and related management shake-up at Minnetonka-based Cogentix Medical has led to a warning letter from Nasdaq saying the company could be delisted…
Ethiopia lacks trained surgeons to combat rheumatic valvular heart disease in kids. A Minnesota-led effort is changing that.
It topped earnings estimates, but investors continue to focus on a lagging operating margin.
It will work with Qualcomm to develop devices to transit glucose levels in real time.
FDA-convened panel said stroke-prevention product appears safe and effective.
Health care is big business in America — 17.5 cents of every dollar spent in the U.S. in 2014 went to pay for it. Minnesota…
Franken, Klobuchar had sought explanation of how review was misplaced, findings unreported.
The medical device maker said gynecology is among the most underserved specialty procedure areas.
The nonprofit Children's Minnesota health system is in the midst of a yearlong clinical trial looking at monitoring of hour-by-hour glucose trends each week, instead of each quarter
The group is part of an Obama administration initiative to help spur manufacturing in the U.S.
Ed Schuck got a new lung in 2003, and he put it to good use. The south Minneapolis native and med-tech entrepreneur used his transplanted…
Responsive hopes to make the costs of knee and hip devices more reasonable.
Just a year after executing the biggest med-tech acquisition ever, Medtronic PLC is hiring a new chief financial officer with a deep background in banking.…
New products that are not yet approved by regulators are key to making the deal work.
The shareholders of the last giant medtech company based in Minnesota are being rewarded with a giant premium.
Shares spiked 11 percent as earnings beat expectations.
Medtronic PLC scored an industry first this month with U.S. approval to start selling its leadless pacemaker, Micra, which represents the first entry in what…
The company's stock jumped as St. Jude offset woes in heart devices.
One of the bedside breathing units overheated, caught fire.
At issue is reinstatement of shareholder suit tied to company's "inversion."
Company has said review of its Infuse product did not reveal any new types of problems.
Medtronic collected data on thousands of patients given its Infuse device, uncovering complications. The problems went unreported for years – even as scrutiny intensified.
Clinic, device maker have been collaborating on products and are set to publicize the effort.
Coming off a rough stretch, the device maker is aiming for the growth that has been a hallmark.
MD Biosciences seeks to sell a service that will test for virus.
MD Biosciences worked for 6 weeks on diagnostic exam that is attracting interest
Company continues to deny allegations it avoided women and applicants over 40 for sales jobs.
The plaintiff alleged company directors hid information about the move to Ireland and ignored a tax hit for its shareholders.
Decision comes after continuing litigation over mesh products.
Medical device maker Medtronic PLC reported adjusted earnings of $1.06 per share Tuesday morning, meeting Wall Street expectations but dipping by 1 percent compared to the same quarter last year.
At HCMC, new machine gives key images gauging circulation.
The device maker has made deals aplenty since shifting its HQ to Ireland.
Minn. CEO calls legal attack "obscene" in berating U.S. prosecutors
Tiny pacemakers, some Minnesota-made, will undergo deep scrutiny.
The OK allows for earlier treatment than before.
Company hopes its MultiPoint Pacing technology will become the next standard for care.
High hopes are riding on a new generation of tiny pacemakers, but the Minnesota med-tech companies that make them will be working this week to convince medical experts that the devices can be safely tested and eventually extracted from patients' hearts.
Stroke-prevention device was developed in the Twin Cities.
FDA gives company approval to sell MRI-safe CRT defibrillators.
At a time when U.S. health care costs have been rising faster than inflation, the prices for many medical devices have been dropping.
Sales of cardiac devices missed fourth-quarter projections, but new products are coming in '16.
The company is facing new competition in pacemakers, one of its biggest products.
An appeals panel said a lower court was wrong to throw out 11 claims tied to the deal that moved the company to Ireland.
Medical Alley tally for last year was highest since at least 2009.
Problem with defibrillation leads could cause serious health issues.
Settlement would resolve leftover Covidien dispute.
Big pharma is no stranger to the ad world and will spend $4.5 billion this year trying to get you to ask your doctor. Now, device makers are entering the game.
Sales in its largest division, heart-rhythm devices, fell 10 percent in quarter to $580M.
The company cited the Covidien merger for freeing up $9.3B that it can deliver to shareholders.
Catheter factory will shut down by 2017, cutting about 185 jobs.
An implanted electrode could solve problems of traditional pacemakers for the left side of the heart.
FDA requirements could force an industry shakeout
A state official says the Japanese company may apply for as much as $2 million in state incentives.
The metro area rarely misses out on lists of best places to live and work.
Its focus is on getting new medical devices to market.
Med-tech group goes back to its old name, and roots.
Minneapolis-based Coloplast Corp. is paying $3 million to settle allegations that the company made illegal payments to cause thousands of senior citizens to switch to…
Man stole company plans worth $4.3 million from offices.
The question of the stolen designs' value will weigh heavily on the length of defendant's sentence.
"The whole entire family in that house is gone. Nothing is left," said a friend of the Columbia Heights family.
Inspire Medical Systems product is being offered by more doctors and hospitals.
Infuse, used in 1 million people since 2002, is company's largest product liability headache.
Boston Scientific said parts of the device can break off.
More from Star Tribune